Microscience Completes £25.5M Round, Plans Clinical Programs Feb. 20, 2002 By Nuala Moran No Comments LONDON - Microscience Ltd. raised £25.5 million (US$36.3 million) in a third-round funding, enabling it to put five infectious disease vaccines into clinical trials this year and develop them through to Phase IIb. (BioWorld International)Read More
Proteom Raises £3M To Further Work Around Protein Interactions Feb. 13, 2002 By Nuala Moran No Comments
Proteom Raises £3M To Further Work Around Protein Interactions Feb. 13, 2002 By Nuala Moran No Comments
